Evolus Stock-Based Compensation 2016-2024 | EOLS
Evolus stock-based compensation from 2016 to 2024. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
| Evolus Annual Stock-Based Compensation (Millions of US $) |
|
|---|---|
| 2023 | $16 |
| 2022 | $11 |
| 2021 | $10 |
| 2020 | $11 |
| 2019 | $10 |
| 2018 | $7 |
| 2017 | $1 |
| 2016 | $1 |
| 2015 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.809B | $0.202B |
| Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $177.773B | 23.28 |
| Stryker (SYK) | United States | $129.938B | 31.12 |
| Boston Scientific (BSX) | United States | $110.868B | 35.31 |
| Medtronic (MDT) | Ireland | $108.045B | 15.62 |
| EssilorLuxottica (ESLOY) | France | $101.589B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.362B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.538B | 28.13 |
| ResMed (RMD) | United States | $30.311B | 28.46 |
| Terumo (TRUMY) | Japan | $25.327B | 35.77 |
| Koninklijke Philips (PHG) | Netherlands | $24.600B | 19.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.690B | 15.13 |
| Baxter (BAX) | United States | $17.372B | 12.35 |
| Insulet (PODD) | United States | $12.410B | 55.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.074B | 0.00 |
| Demant (WILYY) | Denmark | $10.259B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.183B | 26.76 |
| BellRing Brands (BRBR) | United States | $7.587B | 35.69 |
| Lantheus Holdings (LNTH) | United States | $5.672B | 14.13 |
| GN Store Nord (GNNDY) | Denmark | $4.766B | 26.76 |
| Haemonetics (HAE) | United States | $4.275B | 21.13 |
| Perrigo (PRGO) | Ireland | $3.753B | 11.38 |
| Envista Holdings (NVST) | United States | $3.327B | 13.73 |
| Prestige Consumer Healthcare (PBH) | United States | $3.210B | 15.28 |
| QuidelOrtho (QDEL) | United States | $2.959B | 16.43 |
| Neogen (NEOG) | United States | $2.848B | 27.40 |
| ICU Medical (ICUI) | United States | $2.591B | 22.87 |
| TG Therapeutics (TGTX) | United States | $2.519B | 70.87 |
| Green Thumb Industries (GTBIF) | United States | $2.398B | 47.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.184B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.063B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.771B | 51.90 |
| Warby Parker (WRBY) | United States | $1.756B | 0.00 |
| InMode (INMD) | Israel | $1.607B | 8.54 |
| Verano Holdings (VRNOF) | United States | $1.442B | 0.00 |
| Owens & Minor (OMI) | United States | $1.333B | 11.62 |
| AdaptHealth (AHCO) | United States | $1.263B | 9.39 |
| National Vision Holdings (EYE) | United States | $1.185B | 37.72 |
| AtriCure (ATRC) | United States | $1.073B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.989B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.714B | 15.20 |
| Cresco Labs (CRLBF) | United States | $0.655B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.650B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.632B | 14.86 |
| Valneva SE (VALN) | France | $0.632B | 0.00 |
| PetIQ (PETQ) | United States | $0.618B | 19.96 |
| Quanterix (QTRX) | United States | $0.611B | 0.00 |
| Surmodics (SRDX) | United States | $0.600B | 37.55 |
| ZimVie (ZIMV) | United States | $0.454B | 38.72 |
| TerrAscend (TSNDF) | Canada | $0.449B | 0.00 |
| Jin Medical (ZJYL) | China | $0.425B | 0.00 |
| Biote (BTMD) | United States | $0.413B | 9.51 |
| OraSure Technologies (OSUR) | United States | $0.350B | 11.26 |
| Aurora Cannabis (ACB) | Canada | $0.338B | 0.00 |
| Cerus (CERS) | United States | $0.331B | 0.00 |
| Zynex (ZYXI) | United States | $0.323B | 44.13 |
| Viemed Healthcare (VMD) | United States | $0.288B | 28.50 |
| MacroGenics (MGNX) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.254B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.241B | 15.18 |
| High Tide (HITI) | Canada | $0.200B | 0.00 |
| Omeros (OMER) | United States | $0.195B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.194B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.181B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.177B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.148B | 71.00 |
| Veru (VERU) | United States | $0.148B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.141B | 20.06 |
| InterCure (INCR) | Israel | $0.134B | 22.69 |
| Jushi Holdings (JUSHF) | United States | $0.120B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.111B | 0.00 |
| Brainsway (BWAY) | Israel | $0.105B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 8.47 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.087B | 0.00 |
| MariMed (MRMD) | United States | $0.081B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.072B | 0.00 |
| Safety Shot (SHOT) | United States | $0.063B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.062B | 0.00 |
| Apyx Medical (APYX) | United States | $0.057B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Bright Green (BGXX) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.045B | 2.94 |
| United-Guardian (UG) | United States | $0.043B | 15.53 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Exagen (XGN) | United States | $0.034B | 0.00 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |